POZEN News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.02.16	Trouble For CTIC, It's A Thumbs Up For BMY, CYCC On Notice Again, VRTX Snubbed (RTTNews)
09.11.15	EARNINGS SUMMARY: Details of POZEN Inc. Q3 Earnings Report (RTTNews)
09.11.15	POZEN Slips To Loss In Q3; Prepares For Launch Of Yosprala In 2016 - Quick Facts (RTTNews)
06.11.15	POZEN and Tribute Announce Effectiveness of Registration Statement on Form S-4 (Businesswire)
10.08.15	EARNINGS SUMMARY: Details of POZEN Inc. Q2 Earnings Report (RTTNews)
22.06.15	POZEN Announces Appointments To Executive Leadership Team - Quick Facts (RTTNews)
18.06.15	EW Gets FDA Nod, BMRN's Achondroplasia Trial Promising, Watch Out For POZN (RTTNews)
08.06.15	Pozen To Acquire Tribute Pharmaceuticals Canada For $146 Mln (RTTNews)
01.06.15	POZEN Says Chairman, CEO John Plachetka Retires, Adrian Adams To Succeed As CEO (RTTNews)
09.03.15	POZEN Turns To Profit In Q4 - Quick Facts (RTTNews)
17.12.14	Pozen: YOSPRALA Gets Second Complete Response Letter From FDA - Quick Facts (RTTNews)
02.12.14	FDA Lifts Hold On FLXN Study, All's Well With CPXX Trial, COMET Woes For EXEL (RTTNews)
01.12.14	POZEN Ends US License Agreement With Sanofi (RTTNews)
17.07.14	GNCA Withdraws Stock Offering, POZN Gets FDA Date, CNCE On Watch (RTTNews)
14.05.14	PERNIX To Buy TREXIMET® Tablets For Migraine From GSK - Quick Facts (RTTNews)
26.04.14	Pozen's PA8140/PA32540 Receives Complete Response Letter From FDA (RTTNews)
02.04.14	Pozen Submits Final Study Report For PA8140/PA32540 Phase 1 Study (RTTNews)
02.01.14	Pozen Promotes Dennis McNamara To SVP And Chief Business Officer - Quick Facts (RTTNews)
22.11.13	Pre-market Movers For Nov 22 (ARIA, ARUN, BIIB, POZN, FL, SPLK, ROST) (RTTNews)
20.11.13	ATRC On The GO, BMRN Gets Panel's Nod, CLVS Opens Purse Strings, POZN Surges (RTTNews)
05.09.13	Pre-market Movers For Sept 5 (BBRY, ASTX, GRPN, POZN, ENVI, CONN, TITN, LNKD) (RTTNews)
05.09.13	THRX Breathes Easy, POZN Pops, RNN Begins Anew, ARIA On The Move (RTTNews)
04.09.13	Sanofi, POZEN Sign Deal For Commercialization Of PA8140/PA32540 Tablets In U.S. (RTTNews)
04.09.13	Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S. (PR Newswire)
29.08.12	POZEN Announces PA32540 Provides Superior Antiplatlet Effects over a Standard of Care Regimen in a Phase 1 Study ("Co-Rx”) (Businesswire)
26.06.12	POZEN Receives Patent on PA Products for Treatment of Cardiovascular Disease and Osteoarthritis (Businesswire)
20.06.12	POZEN Announces FDA Response to Its Phase 1, PA32540 Bioequivalence Study Analyses (Businesswire)
07.06.12	POZEN to Present at the 2012 Wells Fargo Securities Healthcare Conference (Businesswire)
22.05.12	POZEN to Present at the Jefferies 2012 Global Healthcare Conference (Businesswire)
19.05.12	PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 mg) (Businesswire)
08.05.12	POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 Migraine Treatment in 29 European Countries (Businesswire)
01.05.12	POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial Results (Businesswire)
18.04.12	POZEN Announces May 1, 2012 Webcast of First Quarter 2012 Results (Businesswire)
22.03.12	POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of PA32540 (Businesswire)
01.03.12	POZEN to Present at the 24th Annual ROTH Conference (Businesswire)
28.02.12	POZEN Reports Fourth Quarter & Year End 2011 Results (Businesswire)
14.02.12	POZEN Announces February 28, 2012 Webcast of Fourth Quarter & Year End 2011 Results (Businesswire)
02.02.12	POZEN’s Digital Advisory Board to Speak at Annual ePharma Summit (Businesswire)
02.02.12	Preventive Aspirin Use Less Than Optimal in Stroke Survivors Despite Clinical Guidelines (Businesswire)
28.11.11	Catheterization and Cardiovascular Interventions Journal Publishes Results from USpella Registry (Businesswire)
28.11.11	POZEN Monetizes Its Treximet Royalty Stream for $75 Million (Businesswire)
28.11.11	Micromet Initiates Global Phase 2 Trial of Blinatumomab in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (Businesswire)
17.11.11	POZEN to Present at the Piper Jaffray 23rd Annual Healthcare Conference (Businesswire)
17.11.11	lululemon athletica inc. Announces Third Quarter Fiscal 2011 Earnings Conference Call (Businesswire)
17.11.11	Dollar Tree, Inc. Reports Third Quarter Results (Businesswire)
17.11.11	The Bon-Ton Stores, Inc. Announces Third Quarter Fiscal 2011 Results (Businesswire)
17.11.11	Western Asset Premier Bond Fund ("WEA”) Announces Distributions for the Months of December 2011, January & February 2012 (Businesswire)
14.11.11	Data on Provectus’s PV-10 For Metastatic Melanoma Presented at the 2011 International Melanoma Congress (Businesswire)
14.11.11	Abiomed Announces Symphony, an Implantable Synchronized Heart Pump Designed for Chronic Heart Failure Patients, at AHA 2011 (Businesswire)
14.11.11	Positive Results from POZEN Phase 1 Study ("Co-Rx”) Presented At AHA (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu POZEN Inc.

Aktien Top/Flop

Meistgelesene Nachrichten